8-K: Genworth Q3 2025: Strategic Growth Amidst LTC Losses

Genworth Financial reports mixed third-quarter 2025 results, driven by strong net income and strategic CareScout expansion, but offset by a significant increase in long-term care operating losses.

Summary

• Net income for the third quarter of 2025 was $116 million, or $0.28 per diluted share, a significant increase from $51 million in Q2 2025 and $85 million in Q3 2024.
• Adjusted operating income for the quarter was $17 million, or $0.04 per diluted share, down from $68 million in Q2 2025 and $48 million in Q3 2024.
• The Long-Term Care Insurance segment reported an adjusted operating loss of $(100) million, a substantial increase from $(37) million in Q2 2025 and $(46) million in Q3 2024, primarily due to liability remeasurement losses from lower terminations and higher benefit utilization.
• Enact, the mortgage insurance segment, reported adjusted operating income of $134 million, a decrease from $141 million in Q2 2025 and $148 million in Q3 2024, with its loss ratio increasing to 15% from 10% in the prior quarter.
• Enact distributed $110 million in capital returns to Genworth's U.S. life insurance companies and closed a new $435 million revolving credit facility.
• The company announced a new $350 million share repurchase program and executed $76 million in share repurchases during the quarter at an average price of $8.44 per share.
• Strategic highlights include 950 matches with home care providers in the CareScout Quality Network, the acquisition of Seniorly in October to expand into senior living, and the launch of Care Assurance, CareScout's inaugural standalone LTC product.
• Genworth's holding company cash and liquid assets stood at $254 million at quarter-end, including $145 million held for future obligations.
• The GLIC Consolidated RBC ratio was 303%, a slight decrease from 304% in the prior quarter, but still above requirements.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant deterioration in the Long-Term Care Insurance segment's operating loss and the rising loss ratio in Enact, which overshadow the positive net income, strategic advancements in CareScout, and capital return initiatives. While net income improved, the adjusted operating income and key segment performance metrics show concerning trends.

Positives

• Net income significantly increased to $116 million ($0.28 per diluted share) in Q3 2025, up from $51 million in Q2 2025 and $85 million in Q3 2024.
• Strategic expansion of the CareScout platform with 950 home care provider matches, over 95% home care coverage for the aged 65-plus population, the acquisition of Seniorly, and the launch of Care Assurance, a new standalone LTC product.
• A new $350 million share repurchase program was authorized, and $76 million in share repurchases were executed in the quarter, demonstrating a commitment to returning capital to shareholders.
• The Life and Annuities segment showed improved adjusted operating income of $4 million, compared to losses of $(7) million in Q2 2025 and $(27) million in Q3 2024, driven by favorable mortality experience.
• Enact's primary new insurance written (NIW) increased by 6% from the prior quarter to $14,048 million, and 3% from the prior year, indicating strong new business generation.
• Enact's equity increased to $4,320 million from $4,244 million in the prior quarter, and its PMIERs sufficiency ratio remains strong at 162%, $1,904 million above requirements.
• A $34 million tax benefit was recognized related to a release of a portion of the valuation allowance on certain deferred tax assets.

Negatives

• Adjusted operating income decreased significantly to $17 million ($0.04 per diluted share) in Q3 2025, down from $68 million in Q2 2025 and $48 million in Q3 2024.
• The Long-Term Care Insurance segment's adjusted operating loss worsened substantially to $(100) million in Q3 2025, compared to $(37) million in Q2 2025 and $(46) million in Q3 2024, primarily due to higher liability remeasurement losses from lower terminations and higher benefit utilization.
• Enact's loss ratio increased to 15% in Q3 2025, up from 10% in Q2 2025 and 5% in Q3 2024, indicating a deterioration in underwriting performance.
• The GLIC Consolidated RBC ratio slightly decreased to 303% from 304% in the prior quarter and 317% in the prior year.
• Statutory pre-tax loss for U.S. Life Insurance Companies was $(12) million in Q3 2025, worse than the $81 million income in Q2 2025, with the LTC segment contributing a $(75) million loss.
• Holding company cash and liquid assets of $254 million at quarter-end are lower than $369 million in Q3 2024.

Risks

• Inability to successfully launch new lines of business, including long-term care insurance and other products and services pursued with CareScout.
• Failure to maintain the self-sustainability of legacy U.S. life insurance subsidiaries, potentially due to the inability to achieve desired levels of in-force rate actions or delays in future premium rate increases and associated benefit reductions.
• Inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections, and/or models, which could result in inadequate reserves or other adverse results, including those from expected reviews in Q4 2025.
• Impact on holding company liquidity caused by an inability to receive dividends or other capital returns from Enact Holdings, and limited sources of capital and financing requiring additional capital on unfavorable terms.
• Adverse changes to the structure or requirements of Fannie Mae, Freddie Mac, or the U.S. mortgage insurance market, or an increase in loans insured through federal government mortgage insurance programs.
• Inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet PMIERs requirements or minimum statutory capital requirements.
• Changes in economic, market, and political conditions, labor shortages, and fluctuating interest rates, or deterioration in economic conditions, a recession, or a decline in home prices.
• An increase in the cost of care impacting the company's long-term care insurance business.
• Downgrades in financial strength and credit ratings and potential adverse impacts to liquidity.
• Counterparty credit risks, including defaults by counterparties to reinsurance arrangements or derivative instruments.
• Defaults or other events impacting the value of invested assets.
• Litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties.
• Inability to effectively manage information technology systems (including artificial intelligence), cyber incidents, or other failures, disruptions, or security breaches.

Future Outlook

The company expects quarterly adverse variances between actual and expected experience to persist, potentially resulting in future remeasurement losses in its long-term care insurance business. It remains focused on advancing the CareScout growth platform and returning capital to shareholders, supported by Enact's strong cash flows. The company also anticipates potential impacts from changes in economic, market, and political conditions, including new federal tax laws and regulatory changes.

Management Comments

• "I'm proud of the significant progress we've made advancing Genworth's strategic priorities."
• "We advanced the buildout of our CareScout growth platform with the launch of CareScout's inaugural stand-alone long term care insurance product and the acquisition of Seniorly, helping more families understand, find and fund quality care."
• "In addition, the Genworth Board authorized a new $350 million share repurchase program, reaffirming our commitment to returning capital to shareholders."
• "Supported by Enact's strong cash flows, we remain focused on delivering value to our shareholders and to the millions of families we serve."

Industry Context

Genworth's strategic moves with CareScout, including the acquisition of Seniorly and the launch of Care Assurance, align with broader industry trends towards integrated care solutions and addressing the growing demand for long-term care services. The challenges in the legacy LTC segment, marked by higher benefit utilization and lower terminations, reflect persistent industry-wide issues with older long-term care policies. Enact's performance, while showing strong new insurance written, faces an increasing loss ratio, which could be indicative of broader pressures in the mortgage insurance market or specific portfolio dynamics. The focus on capital returns through share repurchases is a common strategy for mature financial services companies with strong cash-generating subsidiaries like Enact.

Comparison to Industry Standards

• NA

Legal Proceedings

• The company mentions ongoing litigation related to AXA S.A. and Santander Cards UK Limited, with potential recovery amounts subject to appeal, significant delays, or other adverse developments.

Stakeholder Impact

• Shareholders: Impacted by the new $350 million share repurchase program and $76 million in repurchases, indicating capital returns. However, the significant LTC losses and declining adjusted operating income could raise concerns about long-term profitability and stock performance.
• Customers (CareScout): Benefit from the expansion of the CareScout Quality Network, the acquisition of Seniorly, and the launch of Care Assurance, offering more options for long-term care planning and services.
• Employees: The company's ability to retain, attract, and motivate qualified employees or senior management is identified as a risk, suggesting potential challenges in human capital management.
• Creditors: Holding company cash and liquid assets of $254 million provide some liquidity, but the mention of 'limited sources of capital and financing and the need to seek additional capital on unfavorable terms' as a risk could be a concern.
• Policyholders (LTC): Directly affected by the performance of the Long-Term Care Insurance segment, with ongoing in-force rate actions (IFAs) and liability remeasurement losses indicating continued challenges in policy management and potential future premium adjustments.

Next Steps

• Genworth Financial will conduct a conference call on November 6, 2025, at 10:00 a.m. (ET) to discuss its third quarter results.
• Enact will hold a conference call on November 6, 2025, at 8:00 a.m. (ET) to discuss its third quarter results.
• The company expects to complete reviews in the fourth quarter of 2025 that could impact estimates, assumptions, and models, potentially leading to inadequate reserves or other adverse results.

Key Dates

Recommendation

The filing presents a mixed bag of results. While net income saw a strong increase and the company is actively returning capital to shareholders through a new $350 million repurchase program, the significant deterioration in the Long-Term Care Insurance segment's operating loss and the rising loss ratio in Enact are major concerns. The strategic investments in CareScout are positive for future growth, but their impact on overall profitability is yet to be fully realized. Given the ongoing challenges in legacy businesses balanced by strategic initiatives and capital returns, a 'hold' recommendation is appropriate as investors await clearer signs of sustainable improvement in core operating segments.

Keywords

Genworth Financial, GNW, SEC Filing, Q3 2025 Earnings, Financial Results, Long-Term Care Insurance, LTC, CareScout, Enact, Mortgage Insurance, Share Repurchase, Capital Allocation, Insurance, Financial Services, Risk-Based Capital, PMIERs